Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
BörsenkürzelTNON
Name des UnternehmensTenon Medical Inc
IPO-datumApr 27, 2022
CEOMr. Steven M. (Steve) Foster
Anzahl der mitarbeiter27
WertpapierartOrdinary Share
GeschäftsjahresendeApr 27
Addresse104 Cooper Ct.
StadtLOS GATOS
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl95032
Telefon14086495760
Websitehttps://www.tenonmed.com/
BörsenkürzelTNON
IPO-datumApr 27, 2022
CEOMr. Steven M. (Steve) Foster
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten